PHLEBOLOGY

该期刊要求在投稿过程中列出每位作者的具体贡献，并在提交的稿件中于致谢部分之后加入“作者贡献”标题，所填信息将在校对阶段显示于该标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊致力于促进研究的开放、透明和可重复性，鼓励作者在符合伦理和法律要求的前提下，将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（如无法共享则说明原因），并在研究中引用这些数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求作者在指定标题下提供伦理批准声明（即使方法部分已包含），若无需伦理批准也须明确说明；凡涉及人类参与者、人类数据或人体组织的研究，必须声明相关伦理委员会或机构审查委员会批准或豁免，并提供委员会全称、所属机构及批准号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该期刊投稿和发表均无需付费；作者可通过Sage Choice计划或开放获取协议付费选择开放获取出版，费用视协议情况可享受折扣或免费，资格取决于通讯作者所属机构在录用时与Sage签订的协议。 模型中文摘要

There are no fees payable to submit or publish in this journal. Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement …

该期刊采用单盲同行评审，审稿人与编辑互动，不公布审稿信息；稿件先经初步评估，不符合指南要求将被退回修改，超出范围或不合适的稿件可能未经同行评审即被直接拒稿，通过初评后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊和Sage高度重视版权侵权、抄袭及其他违反出版最佳实践的行为，并要求作者阅读Sage关于抄袭的完整政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊接受已在预印本服务器上发布的稿件，投稿时须在指定字段填写预印本DOI，并建议在投稿时告知编辑部；同行评审期间不应在预印本服务器上发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循ICMJE要求，临床试验须在首个受试者入组时或之前在WHO认可的公共试验注册机构注册，作为考虑发表的条件，且须在摘要末尾注明试验注册机构名称、网址及注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.